Metabolomics Australia (MA): focused on providing customised service for small molecule analysis, access to world class expertise, analytical technologies and bioinformatics. Breadth of capability across biotechnology, diagnostics, environmental, agriculture, food/beverage and biomedical sciences. Providing specific detection, quantification services and catering to complex investigations and systems wide analyses. ENABLING INNOVATION.
Specific and sensitive drug and hormone quantitation in biological matrices.
The CDCO is an innovative collaborative research centre that provides ADME lead candidate optimisation support and advice to emerging drug discovery programs. Drug candidate optimisation fills a crucial gap between discovery and development by integrating medicinal chemistry and biology with the pharmaceutical sciences to provide a rational means of identifying better drug candidates.
Baker IDI has considerable research expertise in the areas of proteomics, lipidomics, metabolomics, genomics and epigenomics. The DNA & Blood Profiling Facility (commonly referred to as the “omics”) integrates these research disciplines so health problems can be examined from a multifaceted viewpoint. The central idea behind the new facility is [...]
The Drug Delivery Disposition and Dynamics (D4) Theme at the Monash Institute of Pharmaceutical Sciences provides expertise and infrastructure in drug formulation and drug delivery system design and assessment and evaluation of drug formulations/delivery systems in pre-clinical animal models. The facility has particular expertise in overcoming the challenges associated with [...]